Eterna Therapeutics News

Eterna Therapeutics | 8-K: Current report

Mar 22 16:34 ET

Eterna Therapeutics | 10-K/A: Annual report (Amendment)

Mar 18 07:34 ET

Eterna Therapeutics | 10-K: Annual report

Mar 14 16:41 ET

Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cicala Peter

Feb 16 17:33 ET

Eterna Therapeutics | 8-K: Current report

Feb 16 07:31 ET

Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John D. Halpern(9.99%),Katherine H. Halpern(9.99%)

Jan 31 07:06 ET

Eterna Therapeutics | 424B3: Prospectus

Jan 24 16:20 ET

Eterna Therapeutics | EFFECT: Others

Jan 23 00:00 ET

Eterna Therapeutics | 8-K: Current report

Jan 19 00:00 ET

Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nicholas Jason Singer(9.99%),Purchase Capital LLC(9.99%)

Jan 19 00:00 ET

Eterna Therapeutics | CORRESP: CORRESP

Jan 18 22:40 ET

Eterna Therapeutics | UPLOAD: Others

Jan 17 22:44 ET

Eterna Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 16 00:00 ET

Eterna Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jan 12 00:00 ET

Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luther Sanjeev

Jan 3 00:00 ET

Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Luther Sanjeev

Jan 3 00:00 ET

Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clarke Dorothy J

Jan 3 00:00 ET

Eterna Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Charles Cherington(19.99%)

Dec 22, 2023 12:05 ET

Eterna Therapeutics | 8-K: Current report

Dec 20, 2023 16:20 ET

Eterna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-IAF, LLC(9.99%)

Dec 20, 2023 15:24 ET